- Home
- LWLG vs ABSI Comparison
LWLG vs ABSI Comparison
Compare LWLG & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LWLG | ABSI |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 846.4M | 997.8M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LWLG | ABSI |
|---|---|---|
| Price | $5.22 | $8.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.96 |
| AVG Volume (30 Days) | 2.5M | ★ 2.7M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.79 | 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | $236,855.00 | ★ $4,534,000.00 |
| Revenue This Year | N/A | $215.96 |
| Revenue Next Year | N/A | $319.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 147.74 | N/A |
| 52 Week Low | $2.84 | $2.24 |
| 52 Week High | $18.71 | $12.06 |
Technical Indicators
Market Signals| Indicator | LWLG | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 37.15 | 40.77 |
| Support Level | $3.81 | $6.69 |
| Resistance Level | $5.65 | $10.03 |
| Average True Range (ATR) | 0.30 | 0.54 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 15.89 | 0.81 |
Price Performance
Historical ComparisonAbout LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.